InspireMD, Inc. (NSPR)
USD 2.89
(-0.34%)
USD 2.89
(-0.34%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.59 Million USD | -1.18% |
| 2022 | 1.61 Million USD | 34.39% |
| 2021 | 1.2 Million USD | 20.22% |
| 2020 | 999 Thousand USD | 52.99% |
| 2019 | 653 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 2.68 Million USD | -49.75% |
| 2015 | 5.33 Million USD | -40.04% |
| 2014 | 8.89 Million USD | -8.99% |
| 2013 | 9.77 Million USD | 94.78% |
| 2012 | 5.01 Million USD | 5238.3% |
| 2011 | 94 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.32 Million USD | -9.5% |
| 2024 Q1 | 1.46 Million USD | -8.28% |
| 2023 Q3 | 1.06 Million USD | -23.49% |
| 2023 FY | 1.59 Million USD | -1.18% |
| 2023 Q1 | 1.49 Million USD | -7.19% |
| 2023 Q2 | 1.38 Million USD | -7.34% |
| 2023 Q4 | 1.59 Million USD | 50.19% |
| 2022 Q2 | 1.77 Million USD | 62.6% |
| 2022 Q3 | 1.67 Million USD | -5.47% |
| 2022 Q4 | 1.61 Million USD | -3.76% |
| 2022 Q1 | 1.09 Million USD | -9.16% |
| 2022 FY | 1.61 Million USD | 34.39% |
| 2021 Q4 | 1.2 Million USD | -3.3% |
| 2021 FY | 1.2 Million USD | 20.22% |
| 2021 Q3 | 1.24 Million USD | -5.62% |
| 2021 Q2 | 1.31 Million USD | 3.22% |
| 2021 Q1 | 1.27 Million USD | 27.63% |
| 2020 Q1 | 911 Thousand USD | 39.51% |
| 2020 Q2 | 850 Thousand USD | -6.7% |
| 2020 FY | 999 Thousand USD | 52.99% |
| 2020 Q3 | 1.27 Million USD | 49.88% |
| 2020 Q4 | 999 Thousand USD | -21.59% |
| 2019 Q3 | 1.05 Million USD | -4.02% |
| 2019 Q4 | 653 Thousand USD | -37.87% |
| 2019 FY | 653 Thousand USD | 0.0% |
| 2019 Q1 | 1.13 Million USD | 0.0% |
| 2019 Q2 | 1.09 Million USD | -3.78% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2016 Q1 | 4.29 Million USD | -19.48% |
| 2016 FY | 2.68 Million USD | -49.75% |
| 2016 Q4 | 2.68 Million USD | -26.68% |
| 2016 Q2 | 3.91 Million USD | -8.73% |
| 2016 Q3 | 3.65 Million USD | -6.74% |
| 2015 Q1 | 8.04 Million USD | -9.53% |
| 2015 Q4 | 5.33 Million USD | -14.94% |
| 2015 Q3 | 6.27 Million USD | -12.6% |
| 2015 Q2 | 7.17 Million USD | -10.85% |
| 2015 FY | 5.33 Million USD | -40.04% |
| 2014 Q2 | 9.92 Million USD | 0.77% |
| 2014 FY | 8.89 Million USD | -8.99% |
| 2014 Q1 | 9.84 Million USD | 0.0% |
| 2014 Q4 | 8.89 Million USD | -8.41% |
| 2014 Q3 | 9.71 Million USD | -2.13% |
| 2013 FY | 9.77 Million USD | 94.78% |
| 2013 Q2 | 6.46 Million USD | -12.51% |
| 2013 Q3 | 7.38 Million USD | 14.3% |
| 2013 Q1 | 7.38 Million USD | 14.3% |
| 2012 Q4 | 6.46 Million USD | 14.66% |
| 2012 Q3 | 5.63 Million USD | 12.25% |
| 2012 FY | 5.01 Million USD | 5238.3% |
| 2012 Q1 | - USD | -100.0% |
| 2012 Q2 | 5.02 Million USD | 0.0% |
| 2011 Q1 | 1.45 Million USD | 0.0% |
| 2011 FY | 94 Thousand USD | 0.0% |
| 2011 Q2 | 268 Thousand USD | -81.53% |
| 2011 Q3 | 183 Thousand USD | -31.72% |
| 2011 Q4 | 94 Thousand USD | -48.63% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.706% |
| Nemaura Medical Inc. | 20.03 Million USD | 92.037% |
| NeuroPace, Inc. | 72.39 Million USD | 97.797% |
| LENSAR, Inc. | 2.3 Million USD | 30.922% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 78.288% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 0.0% |
| Apyx Medical Corporation | 38.5 Million USD | 95.857% |
| Cutera, Inc. | 431.91 Million USD | 99.631% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 89.797% |
| BioSig Technologies, Inc. | 452 Thousand USD | -252.876% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 95.933% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.905% |
| Axonics, Inc. | 27.61 Million USD | 94.225% |
| IRIDEX Corporation | 2.74 Million USD | 41.916% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 97.986% |
| TELA Bio, Inc. | 42.78 Million USD | 96.272% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -332.249% |
| RxSight, Inc. | 3.01 Million USD | 47.045% |
| Align Technology, Inc. | 96.96 Million USD | 98.355% |
| INVO Bioscience, Inc. | 8.68 Million USD | 81.632% |
| electroCore, Inc. | 626 Thousand USD | -154.792% |
| Telesis Bio, Inc. | 34.38 Million USD | 95.361% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 84.471% |
| Quipt Home Medical Corp. | 98.94 Million USD | 98.388% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 94.507% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 32.07% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 89.544% |
| Dynatronics Corporation | 6.68 Million USD | 76.151% |
| Modular Medical, Inc. | 1.19 Million USD | -34.034% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -508.779% |
| Talis Biomedical Corporation | 19.66 Million USD | 91.89% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -16.846% |
| InMode Ltd. | 9.01 Million USD | 82.311% |
| Envoy Medical, Inc. | 404 Thousand USD | -294.802% |
| Bruker Corporation | 1.37 Billion USD | 99.884% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -2698.246% |
| DexCom, Inc. | 2.59 Billion USD | 99.939% |
| Nexalin Technology, Inc. | 4463.00 USD | -35638.293% |
| PAVmed Inc | 48.72 Million USD | 96.727% |
| Viveve Medical, Inc. | 5.34 Million USD | 70.181% |
| Cerus Corporation | 95.99 Million USD | 98.339% |
| Movano Inc. | 252 Thousand USD | -532.937% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 95.192% |
| Nexalin Technology, Inc. | 4463.00 USD | -35638.293% |
| IceCure Medical Ltd | 599 Thousand USD | -166.277% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.616% |
| enVVeno Medical Corporation | 1.4 Million USD | -13.766% |
| 908 Devices Inc. | 5.94 Million USD | 73.171% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 88.559% |
| Orthofix Medical Inc. | 134.19 Million USD | 98.811% |
| Surmodics, Inc. | 29.4 Million USD | 94.576% |
| Nuwellis, Inc. | 981 Thousand USD | -62.589% |
| Outset Medical, Inc. | 136.18 Million USD | 98.829% |
| Venus Concept Inc. | 79.69 Million USD | 97.999% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 98.771% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 97.731% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 81.003% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -69.624% |
| Inogen, Inc. | 21.92 Million USD | 92.725% |
| IRadimed Corporation | 2.04 Million USD | 21.93% |
| MaxCyte, Inc. | 18.74 Million USD | 91.49% |
| Pulmonx Corporation | 41.42 Million USD | 96.15% |
| PAVmed Inc. | 48.72 Million USD | 96.727% |
| iCAD, Inc. | 461 Thousand USD | -245.987% |
| OrthoPediatrics Corp. | 23.76 Million USD | 93.287% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 20.11% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -224.193% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -764.967% |
| SI-BONE, Inc. | 38.99 Million USD | 95.909% |
| Semler Scientific, Inc. | 70 Thousand USD | -2178.571% |
| Beyond Air, Inc. | 17.83 Million USD | 91.058% |
| FONAR Corporation | 41.67 Million USD | 96.173% |
| AxoGen, Inc. | 69.29 Million USD | 97.698% |
| Biotricity, Inc. | 23.87 Million USD | 93.32% |
| Cytosorbents Corporation | 18.31 Million USD | 91.29% |
| ZimVie Inc. | 521.92 Million USD | 99.694% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 96.834% |
| Inari Medical, Inc. | 32.04 Million USD | 95.023% |
| UFP Technologies, Inc. | 46.03 Million USD | 96.535% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 20.11% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 48.064% |
| Sight Sciences, Inc. | 35.41 Million USD | 95.496% |
| Insulet Corporation | 1.44 Billion USD | 99.89% |
| Profound Medical Corp. | 7.9 Million USD | 79.811% |
| Bioventus Inc. | 409.47 Million USD | 99.61% |
| BrainsWay Ltd. | 471 Thousand USD | -238.641% |
| BIOLASE, Inc. | 17.91 Million USD | 91.094% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -53.907% |
| Tenon Medical, Inc. | 1.17 Million USD | -35.976% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -59.182% |
| CVRx, Inc. | 30.61 Million USD | 94.79% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.93% |
| Sintx Technologies, Inc. | 4.24 Million USD | 62.426% |
| Acutus Medical, Inc. | 38.47 Million USD | 95.855% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 20.05% |
| NanoVibronix, Inc. | 5000.00 USD | -31800.0% |
| Quanterix Corporation | 41.46 Million USD | 96.153% |
| LivaNova PLC | 640.4 Million USD | 99.751% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 46.666% |
| Varex Imaging Corporation | 469.5 Million USD | 99.66% |
| Vivani Medical, Inc. | 20.69 Million USD | 92.293% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 32.07% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -103.704% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.829% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.691% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 16.185% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -562.166% |
| Spectral AI, Inc. | 1.28 Million USD | -23.739% |
| Hyperfine, Inc. | 185 Thousand USD | -762.162% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.17% |
| Biomerica, Inc. | 785 Thousand USD | -103.185% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -254.852% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -330.959% |
| Silk Road Medical, Inc | 84.63 Million USD | 98.115% |